NUVATION BIO INC (NUVB) Institutional Ownership

NUVB is currently held by 4 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $8.05M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Abrams Capital Management, which reported ownership valued at approximately $5.45M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Abrams Capital Management's NUVB position is now estimated to be worth approximately $7.67M, representing an estimated gain of +40.79% since the filing period.

Major shareholders tracked on this page include Abrams Capital Management, Renaissance Technologies LLC, Greenlight Capital, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward NUVATION BIO INC (NUVB).